tolvaptan has been researched along with Hypertension, Renal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bankir, L; Bouby, N; Ritz, E | 1 |
| Torra, R | 1 |
2 review(s) available for tolvaptan and Hypertension, Renal
| Article | Year |
|---|---|
Vasopressin: a novel target for the prevention and retardation of kidney disease?
Topics: Animals; Benzazepines; Disease Progression; Humans; Hypertension, Renal; Incidence; Prevalence; Renal Insufficiency, Chronic; Tolvaptan; Vasopressins | 2013 |
[Treatment of autosomal dominant polycystic kidney disease].
Topics: Adult; Aged; Animals; Benzazepines; Disease Models, Animal; Female; Glomerular Filtration Rate; Humans; Hypertension, Renal; Kidney; Male; Middle Aged; Models, Biological; Molecular Targeted Therapy; Organ Size; Polycystic Kidney, Autosomal Dominant; Renal Replacement Therapy; Renin-Angiotensin System; Signal Transduction; Somatostatin; Tolvaptan; TOR Serine-Threonine Kinases; TRPP Cation Channels; Young Adult | 2014 |